Immudyne, Inc. (IMMD) insider have most recently took part in a trading activity. On Dec 5, 2017 Schreiber Justin, President, Immudyne PR, 10% Owner bought 25,133 shares having total worth of $9,802 at the price of $0.39 per share, following the transaction a total of 3,393,693 shares owned by Schreiber Justin. Before this latest buy, Schreiber Justin purchased IMMD at 3 other times during the past twelve months, for a total investment of $21,305 at an average of $0.41 per share.
The stock has experienced a total of 3 insider trades in the past three months. These trades include 3 buy trades. Furthermore, over the past 12 months , the stock was traded 3 times by insiders. an employee of the company was the buyer in 3 instances.
|Time Frame||Number of Insider Buy||Number of Insider Sell||Stock Price Change(%)|
Shares of Immudyne, Inc. (IMMD) traded down 6.92% on Dec 5, 2017, hitting $0.36. 101,725 shares of the company’s stock traded hands. Immudyne, Inc. has a 52 week low of $0.21 and a 52 week high of $0.79. The company’s market cap is $0 million.
Immudyne, Inc., manufacture, distribute and sell natural immune support products. The product of the company include ‘Beta glucans’ which is biological response modifiers that support the immune system.
Latest posts by William White (see all)
- Insider Trading Update: Immersion Corporation $IMMR - December 15, 2017
- Insider Trading in Focus: Depomed, Inc. $DEPO - December 15, 2017
- Notable Insider Trading: Safety, Income and Growth, Inc. $SAFE - December 15, 2017